CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial.
- DOI
- 10.1016/j.omton.2025.201081
- Published
- 2025 Dec 18
- Container
- Molecular therapy. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2025.201081,
title = {CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial.},
author = {Katsin M and Dormeshkin D and Migas A and Karas O and Shman T and Serada Y and Khalankova Y and Klych H and Lutskovich D and Lukoika A and Meleshko A},
year = {2025},
journal = {Molecular therapy. Oncology},
doi = {10.1016/j.omton.2025.201081},
url = {https://doi.org/10.1016/j.omton.2025.201081}
}RIS
TY - JOUR TI - CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial. AU - Katsin M AU - Dormeshkin D AU - Migas A AU - Karas O AU - Shman T AU - Serada Y AU - Khalankova Y AU - Klych H AU - Lutskovich D AU - Lukoika A AU - Meleshko A PY - 2025 JO - Molecular therapy. Oncology DO - 10.1016/j.omton.2025.201081 UR - https://doi.org/10.1016/j.omton.2025.201081 ER -
APA
M, K., D, D., A, M., O, K., T, S., Y, S., Y, K., H, K., D, L., A, L., & A, M. (2025). CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2025.201081
Source records
- pubmed · retrieved 2026-09-27T12:24:06.937Z